ArticleNature communications2026
High-throughput label-free single-cell proteomics enabled by multicolumn NanoLC.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mass spectrometry (MS)-based single-cell proteomics (SCP) enables proteome-wide analysis at single-cell resolution, offering insights into cellular heterogeneity, biological processes, and disease mechanisms. However, conventional nanoLC-MS workflows are constrained by long gradients and low throughput, limiting their application to small cohorts. Here, we present a multicolumn nanoLC-MS platform that achieves 5-minute separation windows with 100% duty cycles at ~100 nL/min, enabling the analysis of up to 288 single cells per day. The system provides stable peptide separation, negligible carryover, and robust retention-time reproducibility across nearly 1200 consecutive injections. We successfully analyze more than 4000 samples at nearly 288 samples per day (SPD) throughput. The platform identifies ~5000 proteins per 250 pg digest injection and an average of ~4000 proteins per single HeLa cell with maxima exceeding 5100, which is comparable to state-of-the-art longer-gradient workflows. Quantitative benchmarking with mixed-species standards confirm the quantitative accuracy is largely maintained during extended acquisition. Applying the workflow to 783 LPS-treated RAW264.7 macrophages reveals substantial cellular heterogeneity under a uniform inflammatory stimulus. Together, these results establish a robust and scalable platform for high-throughput SCP, enabling thousands of single-cell analyses within a single study while maintaining deep proteome coverage and biological interpretability.
Indexed as
Identifiers
42918804What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.